Source: Allergan Plc, the maker of wrinkle treatment Botox, agreed to buy Kythera Biopharmaceuticals Inc. for about $2.1 billion to add treatments for double chins and male pattern baldness. The cash and stock transaction values Kythera at $75 a share, the companies said Wednesday in a statement. That's about 24…...